Prioritising Patient Safety with PMS
Legislation has been recently introduced which significantly impacts manufacturers of medical devices. Effective June 16, 2025, the post-market surveillance (PMS) requirements means that UK manufacturers must now have a robust process in place to monitor the safety and performance of medical devices after they are placed on the market. The process introduced will vary by […]
Continue Reading
